PCSK9 inhibitors and diabetes risk: a question worth asking?

Sattar, N. (2016) PCSK9 inhibitors and diabetes risk: a question worth asking? European Heart Journal, 37(39), pp. 2990-2992. (doi:10.1093/eurheartj/ehw346) (PMID:27562223)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Sattar, Professor Naveed
Authors: Sattar, N.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:European Heart Journal
Publisher:Oxford University Press
ISSN:0195-668X
ISSN (Online):1522-9645
Published Online:25 August 2016

University Staff: Request a correction | Enlighten Editors: Update this record